Knowledge about human papillomavirus transmission and prevention among physicians in Rio de Janeiro state, Brazil.
Journal
Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
10
2022
accepted:
14
11
2022
medline:
28
4
2023
pubmed:
26
4
2023
entrez:
26
4
2023
Statut:
epublish
Résumé
This study aimed to assess physicians' knowledge about human papillomavirus infection and its prevention. Descriptive web-based survey with 15 objective questions targeted to physicians affiliated with the Regional Council of Medicine from Rio de Janeiro state, Brazil. Participants were invited by e-mail and the Council social networks, between January and December 2019. The study sample had 623 participants, with a median age of 45 years, predominantly women (63%). The most frequent specialties were Obstetrics and Gynecology (21.1%), Pediatrics (11.2%), and Internists (10.5%). Concerning human papillomavirus knowledge, 27.9% of the participants were able to identify accurately all possible forms of transmission, and none of them could recognize all the risk factors of infection. Nevertheless, 95% recognized that asymptomatic infection could occur in both sexes. Regarding knowledge about clinical manifestations, diagnosis, and screening, only 46.5% were able to identify all human papillomavirus-related cancers, 42.6% were aware of the periodicity of Pap smears, and 39.4% indicated that serological test was not adequate for diagnosis. The recommended age group for human papillomavirus vaccination was recognized by 94% of the participants, as well as the need for a Pap smear and the use of condoms, even after vaccination. There is good knowledge about prevention and screening for human papillomavirus infections; many gaps were identified regarding transmission, risk factors, and associated diseases among physicians in Rio de Janeiro state.
Identifiants
pubmed: 37098929
pii: S0104-42302023000400621
doi: 10.1590/1806-9282.20220291
pmc: PMC10176655
pii:
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20220291Références
Vaccine X. 2019 Aug 05;3:100037
pubmed: 31463471
J Otolaryngol Head Neck Surg. 2017 Oct 26;46(1):61
pubmed: 29073940
PLoS One. 2018 Dec 13;13(12):e0208482
pubmed: 30543647
Clinics (Sao Paulo). 2019 Oct 03;74:e1166
pubmed: 31596339
Rev Bras Epidemiol. 2020 Dec 18;24:e210001
pubmed: 33331411
Int J Environ Res Public Health. 2021 Jan 11;18(2):
pubmed: 33440750
Rev Assoc Med Bras (1992). 2019 Jun 03;65(5):625-632
pubmed: 31166438
Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 2):88-92
pubmed: 25759351
J Obstet Gynaecol Can. 2019 Aug;41(8):1125-1133.e6
pubmed: 31239230
PLoS One. 2018 Dec 31;13(12):e0197648
pubmed: 30596646
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7745-7752
pubmed: 32744701
Vaccine. 2016 Feb 24;34(9):1187-92
pubmed: 26812078
Int J Environ Res Public Health. 2020 Jul 22;17(15):
pubmed: 32707867
BMJ Open. 2018 Jul 28;8(7):e023339
pubmed: 30056394
Vaccine. 2018 Nov 26;36(49):7562-7567
pubmed: 30420044
J Infect Public Health. 2020 Apr;13(4):584-590
pubmed: 31570271
Cancers (Basel). 2021 Dec 22;14(1):
pubmed: 35008197
Sex Transm Dis. 2017 Jan;44(1):42-47
pubmed: 27898573
J Cancer Educ. 2014 Sep;29(3):473-7
pubmed: 24146258
PLoS One. 2015 Oct 26;10(10):e0141003
pubmed: 26501885